New non-invasive bladder cancer test transforms follow-up process

For at least the first two years after treatment, follow-ups tend to be scheduled every three months and then less frequently. Every year, an estimated 76,000 new cases of bladder cancer are diagnosed among the American population, and a further 16,000 Americans die as a result of the disease, according to the American Bladder Cancer Society. For the majority of patients who do survive, non-muscle invasive bladder cancer is characterized by a high recurrence rate – approximately 70% – and the requirement for frequent follow-ups, generally involving an unpleasant and costly cystoscopy procedure under sedation or general anesthetic.

SOCIAL MEDIA

Subscribe to one of our social media channels

close

Subscription Confirmation Required

Go to your email inbox

Go to your email inbox

Go to the inbox of the email
address you just used to sign up.

Open the confirmation email

Open the confirmation email

Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “info@nucleix.com”.

Click the confirmation link

Click the confirmation link

Click on the link inside the
email and you’re good to go.

GOT IT !